Company / Operating Cash Flow
AbbVie Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$19.0B
FY2025
5-year range
$18.8B / $24.9B
FY2021-FY2025
Trend
+1.2%
vs FY2024
Sector context
#2 of 214
Health Care
What the data says
Among 214 Health Care companies, AbbVie is in the top 1% for operating cash flow. Operating Cash Flow returned to growth in FY2025 after 2 years of decline, reaching $19.0B.
Based on SEC 10-K filings.
$19.0B in FY2025 with a 5-year CAGR of +1.6%. Ranks 2nd among 214 companies in Health Care.
Declined from $22.8B to $19.0B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -8.6%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 214This company $19.0B Sector average $663.6M
▼
+2767.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +1.6%, indicating consistent growth.
- In FY2025, operating cash flow increased 1.2% year-over-year.
- Ranks #2 out of 214 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.0B | +1.2% |
| FY2024 | $18.8B | -17.7% |
| FY2023 | $22.8B | -8.4% |
| FY2022 | $24.9B | +9.5% |
| FY2021 | $22.8B | +29.5% |
| FY2020 | $17.6B | +32.0% |
| FY2019 | $13.3B | -0.8% |
| FY2018 | $13.4B | +34.8% |
| FY2017 | $10.0B | +41.5% |
| FY2016 | $7.0B | -6.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026